Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05253170
PHASE3

Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients

Sponsor: Seoul National University Bundang Hospital

View on ClinicalTrials.gov

Summary

This randomized Phase III study aims to show major complication rate of hypofractionation radiation therapy is not inferior, compared to conventional fractionation radiation therapy in breast cancer patients undergoing mastectomy and reconstruction surgery.

Official title: A Randomized Phase III Trial of Hypofractionated Versus Conventionally Fractionated Radiotherapy in Breast Cancer Patients With Reconstruction After Mastectomy

Key Details

Gender

FEMALE

Age Range

19 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

622

Start Date

2022-04-01

Completion Date

2032-12-31

Last Updated

2022-03-11

Healthy Volunteers

Yes

Interventions

RADIATION

Hypofractionation

Radiation regimen of 2.5-3.0Gy x 13-17 fractions +/- sequential boost 0-7 fractions

RADIATION

Conventional Fractionation

Radiation regimen of 1.8-2.0Gy x 23-28 fractions +/- sequential boost 0-5 fractions